questionsmedicales.fr
Système nerveux
Système nerveux central
Encéphale
Prosencéphale
Télencéphale
Cerveau
Cortex cérébral
Cortex sensorimoteur
Cortex visuel
Cortex visuel : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Lésion cérébrale
Imagerie par résonance magnétique
Acuité visuelle
Champ visuel
Agnosie
Troubles de la perception
Électroencéphalogramme
Troubles visuels
Vision des couleurs
Test de Ishihara
Symptômes
5
Hallucinations visuelles
Troubles de la vision
Agnosie visuelle
Reconnaissance des objets
Simultagnosie
Perception des mouvements
Migraine oculaire
Troubles visuels
Prévention
5
Traumatismes crâniens
Maladies vasculaires
Examens ophtalmologiques
Troubles visuels
Migraine
Gestion du stress
Santé oculaire
Lunettes de soleil
Traitements
5
Rééducation visuelle
Thérapie occupationnelle
Agnosie
Thérapie cognitive
Rééducation visuelle
Perception visuelle
Hémianopsie
Exercices de champ visuel
Complications
5
Lésion cérébrale
Troubles cognitifs
Hémianopsie
Vie quotidienne
Agnosie
Interactions sociales
Migraine
Troubles de l'humeur
Troubles visuels
Éducation
Facteurs de risque
5
Traumatismes crâniens
AVC
Vieillissement
Dégénérescence
Antécédents familiaux
Troubles neurologiques
Diabète
Rétinopathie diabétique
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cortex visuel : Questions médicales les plus fréquentes",
"headline": "Cortex visuel : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cortex visuel : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-27",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cortex visuel"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cortex sensorimoteur",
"url": "https://questionsmedicales.fr/mesh/D066191",
"about": {
"@type": "MedicalCondition",
"name": "Cortex sensorimoteur",
"code": {
"@type": "MedicalCode",
"code": "D066191",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.500.814"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cortex visuel primaire",
"alternateName": "Primary Visual Cortex",
"url": "https://questionsmedicales.fr/mesh/D000087642",
"about": {
"@type": "MedicalCondition",
"name": "Cortex visuel primaire",
"code": {
"@type": "MedicalCode",
"code": "D000087642",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A08.186.211.200.885.287.500.814.953.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Cortex visuel",
"alternateName": "Visual Cortex",
"code": {
"@type": "MedicalCode",
"code": "D014793",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Andreas S Tolias",
"url": "https://questionsmedicales.fr/author/Andreas%20S%20Tolias",
"affiliation": {
"@type": "Organization",
"name": "Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA; email: astolias@bcm.edu."
}
},
{
"@type": "Person",
"name": "Paul G Fahey",
"url": "https://questionsmedicales.fr/author/Paul%20G%20Fahey",
"affiliation": {
"@type": "Organization",
"name": "Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA; email: astolias@bcm.edu."
}
},
{
"@type": "Person",
"name": "Jacob Reimer",
"url": "https://questionsmedicales.fr/author/Jacob%20Reimer",
"affiliation": {
"@type": "Organization",
"name": "Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA; email: astolias@bcm.edu."
}
},
{
"@type": "Person",
"name": "Laura Baroncelli",
"url": "https://questionsmedicales.fr/author/Laura%20Baroncelli",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, National Research Council (CNR), I-56124 Pisa, Italy; Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, I-56128 Pisa, Italy. Electronic address: baroncelli@in.cnr.it."
}
},
{
"@type": "Person",
"name": "Alexander S Ecker",
"url": "https://questionsmedicales.fr/author/Alexander%20S%20Ecker",
"affiliation": {
"@type": "Organization",
"name": "Institute for Computer Science, University Göttingen, Göttingen, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Clinical Pharmacokinetics and Pharmacodynamics of Cefepime.",
"datePublished": "2022-06-29",
"url": "https://questionsmedicales.fr/article/35764774",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s40262-022-01137-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Outcomes associated with empiric cefepime for bloodstream infections caused by ceftriaxone-resistant, cefepime-susceptible Escherichia coli and Klebsiella pneumoniae.",
"datePublished": "2023-02-18",
"url": "https://questionsmedicales.fr/article/36804369",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijantimicag.2023.106762"
}
},
{
"@type": "ScholarlyArticle",
"name": "Use of therapeutic drug monitoring to characterize cefepime-related neurotoxicity.",
"datePublished": "2022-12-02",
"url": "https://questionsmedicales.fr/article/36401796",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/phar.2744"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cefepime-modified magnetic nanoparticles and enzymatic colorimetry for the detection of Listeria monocytogenes in lettuces.",
"datePublished": "2022-12-23",
"url": "https://questionsmedicales.fr/article/36586253",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.foodchem.2022.135296"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cefepime population pharmacokinetics and dosing regimen optimization in critically ill children with different renal function.",
"datePublished": "2022-05-20",
"url": "https://questionsmedicales.fr/article/35605841",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmi.2022.05.007"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009420"
},
{
"@type": "ListItem",
"position": 3,
"name": "Système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002490"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphale",
"item": "https://questionsmedicales.fr/mesh/D001921"
},
{
"@type": "ListItem",
"position": 5,
"name": "Prosencéphale",
"item": "https://questionsmedicales.fr/mesh/D016548"
},
{
"@type": "ListItem",
"position": 6,
"name": "Télencéphale",
"item": "https://questionsmedicales.fr/mesh/D013687"
},
{
"@type": "ListItem",
"position": 7,
"name": "Cerveau",
"item": "https://questionsmedicales.fr/mesh/D054022"
},
{
"@type": "ListItem",
"position": 8,
"name": "Cortex cérébral",
"item": "https://questionsmedicales.fr/mesh/D002540"
},
{
"@type": "ListItem",
"position": 9,
"name": "Cortex sensorimoteur",
"item": "https://questionsmedicales.fr/mesh/D066191"
},
{
"@type": "ListItem",
"position": 10,
"name": "Cortex visuel",
"item": "https://questionsmedicales.fr/mesh/D014793"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cortex visuel - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cortex visuel",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cortex visuel",
"description": "Comment diagnostiquer une lésion du cortex visuel ?\nQuels tests évaluent la fonction visuelle ?\nQuels signes indiquent une dysfonction du cortex visuel ?\nQuel rôle joue l'électroencéphalogramme (EEG) ?\nComment évaluer la vision des couleurs ?",
"url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Cefepime#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cortex visuel",
"description": "Quels sont les symptômes d'une lésion du cortex visuel ?\nComment se manifeste l'agnosie visuelle ?\nQu'est-ce que l'hémianopsie ?\nQuels troubles peuvent affecter la perception des mouvements ?\nQuels symptômes indiquent une migraine occulaire ?",
"url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Cefepime#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cortex visuel",
"description": "Comment prévenir les lésions cérébrales ?\nQuels examens réguliers sont recommandés ?\nComment réduire le risque de migraines ?\nQuels conseils pour protéger la santé oculaire ?\nComment gérer le stress pour prévenir les troubles visuels ?",
"url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Cefepime#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cortex visuel",
"description": "Quels traitements existent pour les troubles visuels ?\nComment traiter l'agnosie visuelle ?\nQuels médicaments peuvent aider les migraines visuelles ?\nComment la rééducation visuelle fonctionne-t-elle ?\nQuels sont les traitements pour l'hémianopsie ?",
"url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Cefepime#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cortex visuel",
"description": "Quelles complications peuvent survenir après une lésion du cortex visuel ?\nComment l'hémianopsie affecte-t-elle la vie quotidienne ?\nQuels risques sont associés à l'agnosie visuelle ?\nQuelles sont les conséquences des migraines fréquentes ?\nComment les troubles visuels peuvent-ils affecter l'éducation ?",
"url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Cefepime#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cortex visuel",
"description": "Quels facteurs augmentent le risque de lésions cérébrales ?\nComment l'âge influence-t-il les troubles visuels ?\nQuels rôles jouent les antécédents familiaux ?\nComment le diabète affecte-t-il la vision ?\nQuels comportements augmentent le risque de migraines ?",
"url": "https://questionsmedicales.fr/mesh/D014793?mesh_terms=Cefepime#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une lésion du cortex visuel ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen neurologique et des imageries cérébrales comme l'IRM sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests évaluent la fonction visuelle ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de champ visuel et d'acuité visuelle sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une dysfonction du cortex visuel ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de la perception visuelle, comme l'agnosie, peuvent indiquer une dysfonction."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'électroencéphalogramme (EEG) ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'EEG peut aider à détecter des anomalies électriques liées à des troubles visuels."
}
},
{
"@type": "Question",
"name": "Comment évaluer la vision des couleurs ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests spécifiques comme le test de Ishihara sont utilisés pour évaluer la vision des couleurs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une lésion du cortex visuel ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles de la vision, des hallucinations visuelles et des difficultés de reconnaissance."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'agnosie visuelle ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agnosie visuelle se manifeste par l'incapacité de reconnaître des objets malgré une vision intacte."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'hémianopsie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hémianopsie est une perte de vision dans une moitié du champ visuel, souvent due à des lésions cérébrales."
}
},
{
"@type": "Question",
"name": "Quels troubles peuvent affecter la perception des mouvements ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles comme la simultagnosie peuvent affecter la perception des mouvements et des objets."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une migraine occulaire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des troubles visuels temporaires, comme des éclairs lumineux ou des taches."
}
},
{
"@type": "Question",
"name": "Comment prévenir les lésions cérébrales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les traumatismes crâniens, adopter un mode de vie sain et contrôler les maladies vasculaires."
}
},
{
"@type": "Question",
"name": "Quels examens réguliers sont recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens ophtalmologiques réguliers peuvent aider à détecter précocement des troubles visuels."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de migraines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs connus, gérer le stress et maintenir une bonne hydratation peuvent aider."
}
},
{
"@type": "Question",
"name": "Quels conseils pour protéger la santé oculaire ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Porter des lunettes de soleil, éviter les écrans excessifs et avoir une alimentation équilibrée."
}
},
{
"@type": "Question",
"name": "Comment gérer le stress pour prévenir les troubles visuels ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de relaxation comme le yoga et la méditation peuvent aider à réduire le stress."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les troubles visuels ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la rééducation visuelle, la thérapie occupationnelle et parfois des médicaments."
}
},
{
"@type": "Question",
"name": "Comment traiter l'agnosie visuelle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie cognitive et des exercices de reconnaissance peuvent aider à traiter l'agnosie."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent aider les migraines visuelles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les triptans et les anti-inflammatoires peuvent soulager les migraines."
}
},
{
"@type": "Question",
"name": "Comment la rééducation visuelle fonctionne-t-elle ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La rééducation visuelle utilise des exercices pour améliorer la perception et la reconnaissance visuelle."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements pour l'hémianopsie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des stratégies de compensation et des exercices de champ visuel peuvent aider à gérer l'hémianopsie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une lésion du cortex visuel ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles cognitifs, des problèmes de coordination et des difficultés d'apprentissage."
}
},
{
"@type": "Question",
"name": "Comment l'hémianopsie affecte-t-elle la vie quotidienne ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hémianopsie peut compliquer la conduite, la lecture et d'autres activités nécessitant une vision complète."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à l'agnosie visuelle ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'agnosie peut entraîner des difficultés dans les interactions sociales et des problèmes d'autonomie."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences des migraines fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des migraines fréquentes peuvent entraîner des troubles de l'humeur, de l'anxiété et des absences au travail."
}
},
{
"@type": "Question",
"name": "Comment les troubles visuels peuvent-ils affecter l'éducation ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les troubles visuels peuvent nuire à l'apprentissage, nécessitant des adaptations scolaires spécifiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de lésions cérébrales ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traumatismes crâniens, les AVC et les maladies neurodégénératives augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il les troubles visuels ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le vieillissement peut entraîner une dégénérescence des cellules nerveuses et des troubles visuels."
}
},
{
"@type": "Question",
"name": "Quels rôles jouent les antécédents familiaux ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de troubles neurologiques peuvent augmenter le risque de dysfonction visuelle."
}
},
{
"@type": "Question",
"name": "Comment le diabète affecte-t-il la vision ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète peut entraîner des complications oculaires comme la rétinopathie diabétique, affectant la vision."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque de migraines ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, le manque de sommeil et une mauvaise alimentation peuvent déclencher des migraines."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA; email: astolias@bcm.edu.
Center for Neuroscience and Artificial Intelligence, Baylor College of Medicine, Houston, Texas 77030, USA.
Department of Electrical and Computer Engineering, Rice University, Houston, Texas 77005, USA.
Publications dans "Cortex visuel" :
3 publications dans cette catégorie
Affiliations :
Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA; email: astolias@bcm.edu.
Center for Neuroscience and Artificial Intelligence, Baylor College of Medicine, Houston, Texas 77030, USA.
Publications dans "Cortex visuel" :
3 publications dans cette catégorie
Affiliations :
Department of Neuroscience, Baylor College of Medicine, Houston, Texas 77030, USA; email: astolias@bcm.edu.
Center for Neuroscience and Artificial Intelligence, Baylor College of Medicine, Houston, Texas 77030, USA.
Publications dans "Cortex visuel" :
3 publications dans cette catégorie
Affiliations :
Institute of Neuroscience, National Research Council (CNR), I-56124 Pisa, Italy; Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, I-56128 Pisa, Italy. Electronic address: baroncelli@in.cnr.it.
Publications dans "Cortex visuel" :
3 publications dans cette catégorie
Affiliations :
Institute for Computer Science, University Göttingen, Göttingen, Germany.
Max Planck Institute for Dynamics and Self-Organization, Göttingen, Germany.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Jamaica Plain VA Medical Center, Boston, Massachusetts 02130, USA.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
National Vision Research Institute, Melbourne, VIC, Australia.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
Laboratory for Experimental Ophthalmology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, Stanford University, Stanford, California 94305.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
Department of Psychology, Yale University, New Haven, Connecticut 06520.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
Laboratoire des systèmes perceptifs, Département d'études cognitives, École normale supérieure, PSL University, CNRS, 75005 Paris, France.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
Interdisciplinary Scientist Training Program, University of Chicago Pritzker School of Medicine, Chicago, IL, United States of America.
Committee on Computational Neuroscience, University of Chicago, Chicago, IL, United States of America.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
Committee on Computational Neuroscience, University of Chicago, Chicago, IL, United States of America.
Department of Neurobiology, University of Chicago, Chicago, IL, United States of America.
Neuroscience Institute, University of Chicago, Chicago, IL, United States of America.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
Committee on Computational Neuroscience, University of Chicago, Chicago, IL, United States of America.
Department of Neurobiology, University of Chicago, Chicago, IL, United States of America.
Neuroscience Institute, University of Chicago, Chicago, IL, United States of America.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
Neuroscience Institute, National Research Council (CNR), I-56124 Pisa, Italy.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
Neuroscience Institute, National Research Council (CNR), I-56124 Pisa, Italy.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
Center for Neuroscience and Artificial Intelligence, Baylor College of Medicine, Houston, TX, USA. eywalker@bcm.edu.
Department of Neuroscience, Baylor College of Medicine, Houston, TX, USA. eywalker@bcm.edu.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
Center for Neuroscience and Artificial Intelligence, Baylor College of Medicine, Houston, USA.
Department of Neuroscience, Baylor College of Medicine, Houston, USA.
Publications dans "Cortex visuel" :
2 publications dans cette catégorie
Affiliations :
Center for Neuroscience and Artificial Intelligence, Baylor College of Medicine, Houston, USA.
Department of Neuroscience, Baylor College of Medicine, Houston, USA.
Publications dans "Cortex visuel" :
Cefepime is a broad-spectrum fourth-generation cephalosporin with activity against Gram-positive and Gram-negative pathogens. It is generally administered as an infusion over 30-60 min or as a prolong...
Cefepime is a first-line agent for empiric sepsis therapy; however, cefepime use may be associated with increased mortality for extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) in ...
This single-center retrospective cohort study included patients admitted from October 2010 to August 2020 who received cefepime or meropenem empirically for sepsis with a blood culture growing ceftria...
Fifty-four patients met inclusion criteria: 36 received meropenem and 18 received cefepime. The median (IQR) treatment durations of cefepime and meropenem were 3 (2-6) days and 7 (5-10) days, respecti...
Mortality was similar between groups, although most patients who received cefepime empirically were ultimately transitioned to a carbapenem to complete the full treatment course. Empiric cefepime was ...
Data evaluating cefepime thresholds associated with neurotoxicity remain limited. The objectives of this study were to evaluate the incidence of cefepime-related neurotoxicity (CRN) in patients with p...
This was a retrospective study of adult inpatients admitted between 2016 and 2018 who received cefepime therapeutic drug monitoring (TDM). Potential CRN cases were identified utilizing a standard defi...
Four hundred eighty-one patients with 503 hospital encounters received cefepime TDM and were included in the analysis. The incidence of CRN was 4.4% (22/503). Patients with CRN had a higher incidence ...
Cefepime should be used cautiously in hospitalized patients with renal dysfunction due to the risk of neurotoxicity. Dose optimization utilizing TDM early in cefepime treatment may minimize adverse ef...
A novel sandwich assay for the detection of L. monocytogenes was designed based on antibiotic magnetic separation and enzymatic colorimetry. PEG-mediated cefepime functionalized magnetic nanoparticles...
Cefepime is commonly used in pediatric intensive care units, where unpredictable variations in the patients' pharmacokinetic (PK) variables may require drug dose adjustments. The objectives of the pre...
Children (aged from 1 month to 18 years; body weight >3 kg) receiving cefepime were included. Cefepime total plasma concentrations were measured using high performance liquid chromatography. Data were...
Fifty-nine patients (median (range) age: 13.5 months (1.1 months to 17.6 years)) and 129 cefepime concentration measurements were included. The cefepime concentration data were best fitted by a one-co...
Appropriate cefepime dosing regimens should take renal function into account. Continuous infusions are required in critically ill children with normal or augmented renal clearance, while intermittent ...
Taniborbactam, an investigational β-lactamase inhibitor that is active against both serine- and metallo-β-lactamases, is being developed in combination with cefepime to treat serious infections caused...
Cefepime has been reported to cause concentration-related neurotoxicity, especially in critically ill patients with renal failure. This evaluation aimed to identify a dosing regimen providing a suffic...
Febrile neutropenia (FN) occurs in up to 80% of patients with hematologic malignancies. Evidence suggests using extended infusions (EI) of beta-lactams can improve outcomes in some populations, but th...
Patients with acute myeloid or lymphocytic leukemia who developed FN between April 2014 and January 2021 were included in this single-center, retrospective study. The primary outcome was to compare me...
Overall, 193 patients were included. Baseline characteristics were similar between groups. Time to defervescence was significantly shorter with EI compared with the SI group (median 48 h [48-100.5] vs...
Despite reduced total daily dose of cefepime, EI cefepime administered as a 1G/0.5 h LD followed 2 h later by 1G q8h/4 h for FN acutely achieves more rapid defervescence than the FDA-approved SI regim...
Kaye KS, Belley A, Barth P, et al....
Five Enterobacter cloacae isolates were subjected to 10-day serial passage in broth microdilution with cefepime, meropenem, or ceftazidime-avibactam to evaluate increases in minimum inhibitory concent...